In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).

TriLink BioTechnologies, a Maravai LifeSciences company (MRVI), has partnered with, Avantor (AVTR) to expand availability of its innovative ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, ...

Maravai Lifesciences Holdings Inc (MRVI) stock saw a decline, ending the day at $5.5 which represents a decrease of $-0.11 or -1.96% from the prior close of $5.61. The stock opened at $5.79 and ...

KURT ORESHACK, the General Counsel of $MRVI, sold 25,000 shares of the company on 01-31-2025 for an estimated $125,750. We received data on the trade from a recent ...

Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...

Justin Barbosa, GM and Vice President of TriLink Discovery, added “By integrating Molecular Assemblies technology into ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cencora COR is slated to report first-quarter fiscal 2025 results on Feb. 05, before market open. In the last reported ...

Revvity, Inc. RVTY is slated to report fourth-quarter 2024 results on Jan. 31, before market open. In the last reported quarter, the company delivered an earnings surprise of 13.27%. RVTY’s ...